glp-1 and gip/glp-1 medications Say What?! A Magic Medication for Weight Loss? Effects, working principles and target

Cell 79 , 43-53.e44

The magnitude of body weight loss for liraglutide-treated rats was stronger than sCT- and vehicle-treated animals

Qsymia is approved for chronic weight management, unlike phentermine monotherapy which has only short-term approval

Effects on Blood Pressure and Lipid Profiles GLP-1 receptor agonists have been shown to decrease systolic blood pressure (SBP) and, to a lesser extent, diastolic blood pressure (DBP)

Most importantly, it provides advice and tools to aid clinicians in selecting suitable alternatives to GLP-1 RAs where there is limited availability

Glucagon-like peptide-1 (GLP-1) has been reported to improve T2DM through the stimulation of insulin-secreting pancreatic -cells (Kreymann et al., 1987